Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

Enrolling by invitation · Phase 1

Conditions studied: HIV-1-infection

In brief

Participants who receive EBT-101 in a parent protocol will be eligible to participate in this long-term follow-up (LTFU) study (EBT-101-002).

Key facts

Study ID

NCT05143307

Run by

Excision BioTherapeutics

People needed

9

Starts

2023-07-11

Expected to finish

2037-04-01

Last updated by the study team

2024-05-14

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Willing and able to provide written, signed informed consent
• Participants who received the investigational study intervention EBT-101 in a parent study

You may not qualify if…

• Participants who did not receive EBT-101 in a parent study

Where it is running

• Quest Clinical Research — San Francisco, California, United States
• Washington University — St Louis, Missouri, United States
• Cooper Health — Camden, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.